Section one: Contracting authority/entity
one.1) Name and addresses
University of Ulster
Block X Room X031, Cromore Road
Coleraine
BT52 1SA
Telephone
+44 2870124227
Country
United Kingdom
NUTS code
UKN - Northern Ireland
National registration number
NIC100166
Internet address(es)
Main address
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Education
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
InflaMab Project MOA Studies
Reference number
Project_27311
two.1.2) Main CPV code
- 73000000 - Research and development services and related consultancy services
two.1.3) Type of contract
Services
two.1.4) Short description
Provision of testing services on research projects
two.1.6) Information about lots
This contract is divided into lots: No
two.1.7) Total value of the procurement (excluding VAT)
Value excluding VAT: £200,000
two.2) Description
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
two.2.4) Description of the procurement
Various works testing on the efficacy of a novel therapeutic drug.
two.2.11) Information about options
Options: Yes
Description of options
It is anticipated the contract will be for 3 years initially with an option to extend for any period up to and including 24 months.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
The estimated total value stated in Section II.1.7 includes the 3 year contract period and will include the option to extend for any period up to and including 24 months.
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Award of a contract without prior publication of a call for competition in the cases listed below
- The procurement falls outside the scope of application of the regulations
Explanation:
The Direct Award complies with PCR Regs:
• 32(5)a where the supplies can be supplied only by an economic operator for the purpose of research, study, and development.
Medicine Discovery Catapult are the only supplier who can carry out all of the necessary testing required on this drug . Consistency is vital for this research and it is necessary that one company handles all of the testing. Much of the work can often be subjective and user dependent. To be confident in the results yielded, one supplier who offers all techniques would be scientifically merited and most economically viable
A contract will not be entered into before 05 January 2023.
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: No
Section five. Award of contract/concession
Contract No
27311
Title
InflaMab Project_MoA studies
A contract/lot is awarded: Yes
five.2) Award of contract/concession
five.2.1) Date of conclusion of the contract
14 December 2022
five.2.2) Information about tenders
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor/concessionaire
Medicine Discovery Catapult
Block 35, Mereside, Alderley Park, Alderley Edge,
Macclesfield
SK10 4ZF
Country
United Kingdom
NUTS code
- UK - United Kingdom
The contractor/concessionaire is an SME
Yes
five.2.4) Information on value of contract/lot/concession (excluding VAT)
Total value of the contract/lot/concession: £200,000
five.2.5) Information about subcontracting
The contract/lot/concession is likely to be subcontracted
Section six. Complementary information
six.4) Procedures for review
six.4.1) Review body
High Court of Justice in Northern Ireland
Royal Courts of Justice, Chichester Street
Belfast
BT1 3JY
Country
United Kingdom
six.4.3) Review procedure
Precise information on deadline(s) for review procedures
Any proceedings alleging that the University is in breach of its duties under the Public Contract Regulations 2015 must be started in the High Court of Northern Ireland, in accordance with the time limits set out in those Regulations. The University will not enter into the contract before the end of a period of at least 10 days beginning with the day after the date on which this voluntary transparency notice is published in the Official Journal.